{
    "2020-03-19": [
        [
            {
                "time": "2018-03-22",
                "original_text": "Coca-Cola, Johnson & Johnson share losses lead Dow's nearly 100-point drop",
                "features": {
                    "keywords": [
                        "Coca-Cola",
                        "Johnson & Johnson",
                        "share losses",
                        "Dow",
                        "100-point drop"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-14",
                "original_text": "Pfizer's Eczema Drug & Pneumococcal Vaccine Succeed in Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eczema Drug",
                        "Pneumococcal Vaccine",
                        "Succeed",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-18",
                "original_text": "The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eczema Drug",
                        "Latestage Study",
                        "Orphan Drug",
                        "Dicerna",
                        "Dyadic",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}